Should I buy Versigent PLC (VGNT) stock or is it too late?
⭐ The most reliable of them, either direction: UBS — 58% of its targets hit on this sector (157 calls tested). It aims for $55 (+13 %), call made on July 10, 2026, maturing on July 10, 2027 (49 d ago).
✅ Reasons to believe
- 100% of analysts rate it a buy (Buy consensus, 8 ratings) — a sign of market conviction.
- Median price target $55, i.e. +12% from the current price ($49).
⚠️ Reasons to hesitate
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
- No dividend: your return depends only on price appreciation.
- A near-unanimous consensus leaves little room for positive surprise — a lot of optimism is already baked in.
The analyst consensus on VGNT
Median target $55 (+12%) · 8 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Versigent PLC now?
We won't decide for you. The facts: 100% of analysts rate it a buy, median target $55 (+12%). Weigh that against valuation and volatility. This is not personalized advice.
Is it too late to invest in Versigent PLC?
Not according to analysts: the median target ($55) is still +12% above the current price ($49). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Versigent PLC still worth investing in?
It depends on the gap between the price ($49) and its estimated value: analysts target $55 on median (+12%), with 100% buys. Cross-check with their real reliability on VGNT and the cautions above. Information, not advice.
What's the main risk in buying VGNT?
A 12-month target is not a guaranteed path: the price can fall in the meantime.
→ Go deeper: the full Versigent PLC profile (consensus, analyst reliability, price target, performance).